137 results
8-K
EX-10.2
TNFA
TNF Pharmaceuticals Inc.
17 Jun 24
Entry into a Material Definitive Agreement
9:04am
Law/Venue. This Agreement shall be governed by and construed under the laws of the State of Delaware. Venue of any litigation arising from … to trial by jury in connection with any litigation or disputes under or in connection with this Agreement.
13. Voluntary. This Agreement is executed
8-K
EX-10.4
TNFA
TNF Pharmaceuticals Inc.
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
to such Indemnified Party or Indemnified Person (as the case may be) of a release from all liability in respect to such Claim or litigation
8-K
EX-10.2
TNFA
TNF Pharmaceuticals Inc.
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
(in whole or in part) against loss with respect thereto.
(t) Litigation. There is no material action, suit, arbitration, proceeding, inquiry … in spoliation in reasonable anticipation of litigation. Without limitation of the foregoing, there has not been, and to the knowledge of the Company
8-K
EX-10.3
TNFA
TNF Pharmaceuticals Inc.
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
(as the case may be) of a release from all liability in respect to such Claim or litigation, and such settlement shall not include any admission as to fault
8-K
EX-10.1
TNFA
TNF Pharmaceuticals Inc.
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
will be complied with, or that the holders of such liability will be protected (in whole or in part) against loss with respect thereto.
(t) Litigation … or any of its subsidiaries has willfully violated 18 U.S.C. §1519 or engaged in spoliation in reasonable anticipation of litigation. Without
8-K
EX-3.1
eoyuuk7g o10z
7 Mar 24
Entry into a Material Definitive Agreement
4:30pm
424B5
xwik0bdvv
17 Aug 22
Prospectus supplement for primary offering
3:00pm